This site is intended for healthcare professionals only
LoginRegister
Dont throw in the bin, please flush it! CDSCO dictum for these 17 medicinesOver 5 lakh Tramadol, Alprazolam tablets worth Rs 20 crore seized,; 5 arrested
Roche Susvimo maintains vision over five years with two refills per year in people with nAMDRoche Susvimo maintains vision over five years with two refills per year in people with nAMD
Fire erupts at Deys Medical plant in Kolkata, no injuries reportedFire erupts at Dey's Medical plant in Kolkata, no injuries reported
Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMROne-shot Dengue vaccine 'DengiAll' completes 70% enrolment of participants in Phase III trial:...
Sun Pharma Gets CDSCO Panel Nod For Alfuzosin-Tadalafil FDC Post-Marketing StudySun Pharma Gets Relief As Delhi HC Bars Use of BERIVITAL, BEZOLIC, DOZE-30 For Trademark...
Sanores Pharma appoints Sanjay Moralwar as Head of ITSenores Pharma appoints Sanjay Moralwar as Head of IT
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in IndiaCDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in...
Sanofi successfully prices euro 1.5 billion bond issueSIL declares profit from operations growth as +6% vs previous year
Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial ProposalNovartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal
Health Ministry Notifies Cosmetics Rules 2025, Empowers States To Suspend LicencesHealth Ministry Notifies Cosmetics Rules 2025, Empowers States To Suspend Licences
Biodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal SprayBiodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal Spray
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic DermatitisCDSCO Panel Accepts Phase I Trial Data for Intas' Denosumab Biosimilar
X